Get my own profile
Public access
View all3 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Beau KilmerDirector, RAND Drug Policy Research CenterVerified email at rand.org
- molly battistelliUCSF - San Francisco, CAVerified email at ucsf.edu
- Darius N. LakdawallaUniversity of Southern CaliforniaVerified email at healthpolicy.usc.edu
- Devin IncertiEntityRisk, Inc.Verified email at entityrisk.com
- Jeroen P JansenAssociate Professor, University of California, San FranciscoVerified email at ucsf.edu
- David P. KennedyRAND CorporationVerified email at rand.org
- David I Auerbachmassachusetts health policy commissionVerified email at alum.mit.edu
- Anupam B. Jena, MD, PhDJoseph P. Newhouse Professor, Harvard Medical SchoolVerified email at hcp.med.harvard.edu
- Joshua A RothDepartment of Pharmacy, University of WashingtonVerified email at uw.edu
- Anna KasunicCarnegie Mellon UniversityVerified email at andrew.cmu.edu
- Jonathan CaulkinsCarnegie Mellon UniversityVerified email at andrew.cmu.edu
- Daniel SheinsonStatistical Researcher at Genentech, Inc.; PhD from University of California, Santa BarbaraVerified email at pstat.ucsb.edu
- Douglas D. HeckathornCornell UniversityVerified email at cornell.edu
- Jessica SaundersCSG Justice CenterVerified email at csg.org
- Jason ShafrinFTI Consulting & University of Southern CaliforniaVerified email at fticonsulting.com
- Jack SheehanJanssen Pharmaceuticals LLCVerified email at its.jnj.com
- Dennis ScanlonPenn StateVerified email at psu.edu
- Dana P GoldmanSol Price School of Public Policy, University of Southern CaliforniaVerified email at usc.edu